PPPA, an acyl-CoA, was a selective inhibitor of cholesterol acyltransferase 2-selective inhibitor (ACAT2), the selective inhibition of ACAT2 in intestine and liver could effectively combat atherosclerosis. This evidence concerns the gene ACAT2 and atherosclerosis.